- Home
- INMD vs EMBC Comparison
INMD vs EMBC Comparison
Compare INMD & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INMD
- EMBC
- Stock Information
- Founded
- INMD 2008
- EMBC 1924
- Country
- INMD Israel
- EMBC United States
- Employees
- INMD N/A
- EMBC N/A
- Industry
- INMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- EMBC Medical/Dental Instruments
- Sector
- INMD Health Care
- EMBC Health Care
- Exchange
- INMD Nasdaq
- EMBC Nasdaq
- Market Cap
- INMD 887.0M
- EMBC 726.8M
- IPO Year
- INMD 2019
- EMBC N/A
- Fundamental
- Price
- INMD $14.30
- EMBC $9.64
- Analyst Decision
- INMD Hold
- EMBC Hold
- Analyst Count
- INMD 6
- EMBC 3
- Target Price
- INMD $17.56
- EMBC $17.00
- AVG Volume (30 Days)
- INMD 1.8M
- EMBC 691.8K
- Earning Date
- INMD 07-31-2025
- EMBC 08-08-2025
- Dividend Yield
- INMD N/A
- EMBC 6.25%
- EPS Growth
- INMD 8.69
- EMBC N/A
- EPS
- INMD 2.29
- EMBC 0.89
- Revenue
- INMD $392,408,000.00
- EMBC $1,079,500,000.00
- Revenue This Year
- INMD $0.16
- EMBC N/A
- Revenue Next Year
- INMD $4.84
- EMBC N/A
- P/E Ratio
- INMD $6.28
- EMBC $10.76
- Revenue Growth
- INMD N/A
- EMBC N/A
- 52 Week Low
- INMD $13.14
- EMBC $9.20
- 52 Week High
- INMD $19.85
- EMBC $21.48
- Technical
- Relative Strength Index (RSI)
- INMD 48.92
- EMBC 41.56
- Support Level
- INMD $13.14
- EMBC $9.54
- Resistance Level
- INMD $14.32
- EMBC $10.34
- Average True Range (ATR)
- INMD 0.40
- EMBC 0.46
- MACD
- INMD 0.05
- EMBC 0.04
- Stochastic Oscillator
- INMD 58.49
- EMBC 36.67
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.
About EMBC Embecta Corp.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.